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Abstract
Background: Early onset bacterial sepsis is a feared complication of the newborn. A large proportion of
infants admitted to the Neonatal Intensive Care Unit (NICU) for suspected sepsis receive treatment with
potent systemic antibiotics while a diagnostic workup is in progress. The gold standard for detecting
bacterial sepsis is blood culture. However, as pathogens in blood cultures are only detected in
approximately 25% of patients, the sensitivity of blood culture is suspected to be low. Therefore, the
diagnosis of sepsis is often based on the development of clinical signs, in combination with laboratory tests
such as a rise in C – reactive protein (CRP). Molecular assays for the detection of bacterial DNA in the
blood represent possible new diagnostic tools for early identification of a bacterial cause.
Methods: A broad range 16S rDNA polymerase chain reaction (PCR) without preincubation was
compared to conventional diagnostic work up for clinical sepsis, including BACTEC blood culture, for early
determination of bacterial sepsis in the newborn. In addition, the relationship between known risk factors,
clinical signs, and laboratory parameters considered in clinical sepsis in the newborn were explored.
Results: Forty-eight infants with suspected sepsis were included in this study. Thirty-one patients were
diagnosed with sepsis, only 6 of these had a positive blood culture. 16S rDNA PCR analysis of blinded
blood samples from the 48 infants revealed 10 samples positive for the presence of bacterial DNA. PCR
failed to be positive in 2 samples from blood culture positive infants, and was positive in 1 sample where
a diagnosis of a non-septic condition was established. Compared to blood culture the diagnosis of bacterial
proven sepsis by PCR revealed a 66.7% sensitivity, 87.5% specificity, 95.4% positive and 75% negative
predictive value. PCR combined with blood culture revealed bacteria in 35.1% of the patients diagnosed
with sepsis. Irritability and feeding difficulties were the clinical signs most often observed in sepsis. CRP
increased in the presence of bacterial infection.
Conclusion: There is a need for PCR as a method to quickly point out the infants with sepsis. However,
uncertainty about a bacterial cause of sepsis was not reduced by the PCR result, reflecting that
methodological improvements are required in order for DNA detection to replace or supplement
traditional blood culture in diagnosis of bacterial sepsis.
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A large proportion of infants admitted to neonatal inten-
sive care units (NICUs) present with signs of sepsis. In
2004, 130 patients or 35.4% of all newborns admitted to
the NICU at Akershus University Hospital (Ahus), Nor-
way, were treated with broad-spectrum systemic antibiot-
ics for suspected bacterial sepsis. However, in only a small
subset of the treated patients was a pathogen actually
identified. Several studies have previously tried to find a
clear-cut definition of sepsis in neonates, based on a com-
bination of clinical signs and laboratory parameters [1-3].
However, diagnosing neonatal sepsis is difficult since
being exposed to known risk factors for sepsis [4-7] is not
a necessity, clinical signs are often vague, and laboratory
parameters are unspecific. Conventional blood culture is
considered the gold standard in the etiological diagnosis
of neonatal bacterial sepsis [1,8]. However, obtaining suf-
ficiently large amounts of blood for culture from neonates
are often difficult [9-12], and it often takes 48–72 hours
to obtain a preliminary positive result. Elevation of C –
reactive protein (CRP) has been a useful marker of sepsis
in many studies [1,2]. Initiation of broad-spectrum sys-
temic antibiotic treatment is based only on the suspicion
of sepsis since no early definitive diagnostic test is yet
available. The clinician accepts some over-treatment
because of the high risk of mortality if sepsis is left
untreated. Two well-documented studies have shown that
relevant pathogens were detected in about 25% of pediat-
ric patients admitted to intensive care units [13,14].
Therefore, if no pathogenic bacterial agent is detected, the
diagnosis of sepsis is based on the development of clinical
signs only, often in combination with a rise in CRP
[11,15].
Detection of bacterial DNA in blood samples of neonates
is suggested to represent a rapid and sensitive supplement
to blood culture in diagnosing bacterial sepsis in neonates
[5,14,16]. However, at present there are no standardised
clinically evaluated methods available for detection of
bacterial DNA in blood samples from neonates. The main
aim of this study was to compare a broad range 16S rDNA
PCR done on whole blood samples without prior enrich-
ment to conventional BACTEC Peds PLUS/F blood culture
for detecting bacterial DNA in blood samples from infants
with suspected sepsis.
In addition, the relationship between known risk factors,
clinical signs, and laboratory parameters in suspected
neonatal sepsis and the diagnosis of sepsis at discharge
from the NICU were explored. Since the suspicion of sep-
sis is based on a number of known risk factors, clinical
signs and laboratory markers, it would be helpful to iden-




Infants with a birth weight (BW) > 1000 grams admitted
to the NICU at Akershus University Hospital with sus-
pected sepsis during their first week of life were included.
All infants included in the study were treated with sys-
temic antibiotics. The regional committee for medical eth-
ics in science in Eastern Norway (REK1) approved the
study and a written parental consent was obtained before
inclusion.
Fifty-two infants were eligible for the study. Four of these
patients were later not included in the analysis because of
incomplete registration forms (3 infants) or missing sam-
ples for blood culture or PCR (1 infant).
Study design
This project was carried out as a prospective non-ran-
domised study. The clinical and laboratory variables reg-
istered at admittance are listed in Table 1 and Table 2.
Microbial analyses
A minimum of 1 ml full blood for conventional BACTEC
Peds PLUS/F blood culture, and 1–2 ml EDTA-blood for
16S rDNA PCR were obtained by standard sterile proce-
dures before starting general systemic antibiotic treat-
ment. Only one blood culture bottle was routinely drawn
from each patient. The bottles for culturing were immedi-
ately incubated. The EDTA-blood samples for PCR were
blinded and stored in room temperature for until 72
hours, divided into plasma and cell fractions, and were
then stored at -70°C before analysis.
PCR reactions and detection limits
PCR reactions were set up to amplify bacterial DNA using
the primer 5'TGAAGAGTTTGATCATGGCTCAG com-
bined with either primer 5'AAGGAGGTGATCCAACCG,
5'TCGTTGCGGGACTTAACC or 5'TACCGCGGCTGCT-
GGCA. The primers react with highly conserved regions of
the bacterial 16S rRNA gene to provide PCR products of
approximately 1500 basepairs (PCR 1), 1100 basepairs
(PCR 2) and 500 basepairs (PCR 3), respectively [17]. All
primers were produced at Eurogentec, Belgium, and are
routinely used in our laboratory for 16S rRNA based iden-
tification of unknown isolates. Each PCR reaction (50 μl)
consisted of 1 × Amplitaq Gold buffer (Applied Biosys-
tems) supplemented with 2.5 U Amplitaq Gold Low DNA
enzyme (Applied Biosystems), 2 mM MgCl2, 0.2 mM
dNTP (Roche) 20 μl template and PCR grade water
(Roche). Cycling conditions included a 5 minute denatur-
ing step at 94°C followed by 30 to 40 cycles of 20 seconds
at 94°C, 20 seconds at 58°C and 60 seconds at 72°C.
Detection limit in cfu/ml (colony forming units, cfu) for
each PCR was established in triplicate reactions of extracts
from blood samples spiked with Staphylococcus aureusPage 2 of 8
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trations (cfu/ml). The spiked blood samples were also
divided in plasma and cell fraction and stored at -70°C.
Nucleic acid was extracted from duplicates of 200 μl sam-
ples of both fractions using the Qiagen Blood kit. DNA
from each extraction was recovered with 100 μl PCR grade
water (Roche). The limit of detection was set to the
number of cfu/ml of blood where all triplicates were pos-
itive. For PCR1 40 cycles of PCR could be used to detect
103 cfu/ml of both E.coli and S.aureus. For PCR2 we were
unable to find conditions where 104 cfu/ml or less could
be detected without also observing contaminants in the
non-spiked controls. For PCR3 35 cycles of PCR could be
used to detect 104 cfu/ml, however additional bands
appeared when increasing the cycle numbers and domi-
nated in samples with 103 cfu/ml or less.
The EDTA blood from newborns with signs of sepsis were
analysed by blinded PCR using conditions PCR 1 and PCR
3 established for the spiked blood samples. PCR results
were considered positive when visible PCR products of
the correct size were found in at least duplicate reactions
in runs with DNA isolated from either the plasma or the
cell fraction. PCR results were considered negative when
Table 1: Comparison of clinical and laboratory parameters on admission in patients with sepsis (Sepsis) and patient with other non-
infectious conditions (Not sepsis)
Maternal parameters Sepsis (n = 31) Not sepsis (n = 17) p
Maternal fever > 38°C 10/31 5/17 0.25
Maternal antibiotics 10/31 0/17 0.00
Premature rupture of membranes 11/31 4/17 0.18
Infant parameters
Gestational age (GA) < 37 weeks 3/31 6/17 0.03
Irritability 11/31 1/17 0.02
Fever > 38°C 7/31 5/17 0.23
Heart rate > 160 beats per minute 6/31 3/17 0.30
Respiratory rate > 60 per minute 11/31 5/17 0.23
Apgar score at 5 min < 8 3/31 7/17 0.01
Feeding difficulties 6/31 0/17 0.06
Capillary refill time > 3 seconds 7/31 3/17 0.27
Oxygen saturation (SaO2) < 88% 6/31 4/17 0.27
BE (base excess) < -5 0/31 5/17 0.00
Leukocyte count < 5 1/31 0/17 0.64
Platelets < 100 2/31 1/17 0.45
Blood glucose < 2,5 mmol/l 4/31 2/17 0.35
CRP mg/l 47.0 ± 33.8 8.5 ± 2.5 0.00
Highest CRP mg/l 66.8 ± 36.7 9.1 ± 2.7 0.00Page 3 of 8
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were considered inconclusive when single positive runs
could not be repeated [18].
Attempts to sequence the positive PCR products were
made using the PCR primers, standard Big Dye terminator
cycle sequencing by capillary gel electrophoresis (Applied
Biosystems). If a sequence was established, an identity
match to the region between the primers was then
searched in the Bio-Informatic Bacterial identification
database (BiBi, Lyon France).
Data analysis
Included patients were allocated into one of two groups,
S (Sepsis) and nS (not Sepsis), based on the diagnosis at
discharge. The following patients in the S group were dis-
charged from the NICU with the diagnosis of sepsis:
infants with suspicion of sepsis and an elevated CRP,
development of clinical signs consistent of sepsis, a
marked CRP-rise, or detection of a relevant pathogen in
blood culture. Patients in the S group were further divided
into two groups, "proven sepsis" (with detection of a
pathogen bacteria in blood culture or by PCR), and "non-
Table 2: Comparison of clinical and laboratory parameters in patients with proven sepsis (sepsis with positive blood culture and/or 
detection of bacterial DNA in blood) and patients with non-proven sepsis (no bacterial agent found)
Maternal parameters Proven sepsis Non-proven sepsis p
Maternal fever > 38°C 1/11 10/20 0.02
Maternal antibiotics 2/11 8/20 0.15
Premature rupture of membranes 3/11 8/20 0.25
Normal vaginal delivery 5/11 5/20 0.16
Infant parameters
Gestational age (GA) < 37 weeks 0/11 2/20 0.40
Irritability 6/11 6/20 0.13
Fever > 38°C 2/11 5/20 0.32
Heart rate >160 beats per minute 2/11 3/20 0.37
Respiratory rate > 60 per minute 3/11 8/20 0.21
Apgar at 5 min < 8 1/11 3/20 0.40
Feeding difficulties 2/11 4/20 0.32
Capillary refill time > 3 seconds 1/11 7/20 0.11
Oxygen saturation (SaO2) < 88% 3/11 3/20 0.26
BE < -5 0/11 0/20 1.0
Leukocyte count < 5 0/11 1/20 0.47
Platelets < 100 2/11 0/20 0.12
Blood glucose < 2,5 mmol/l 0/11 3/20 0.25
CRP mg/l 49.3 ± 41.3 42.7 ± 29.1 0.60
Highest CRP mg/l 71.7 ± 41.6 70.3.6 ± 35.5 0.92Page 4 of 8
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either method). Risk factors, clinical signs and laboratory
parameters were compared between the two groups S and
nS, and between "proven sepsis" and "non-proven sep-
sis". Nonparametric test for independent samples (the
Mann-Whitney Test) was used to compare linear variables
between groups. For categorical variables the Fisher exact
test was used. A p-level of < 0.05 was considered statisti-
cally significant. The statistical program SPSS version
12.01 was used for data analysis.
Results
Forty-eight infants with suspected sepsis were included in
this study. At discharge from the NICU, 31 patients were
diagnosed with sepsis, including both bacterial proven
and non-proven sepsis, and 17 infants were discharged
with a diagnosis of other non-infectious diseases. Of new-
borns diagnosed with sepsis, six infants had a positive
blood culture and nine had a positive PCR.
Comparison of 16S rDNA PCR and blood culture
The results are presented in Table 3 and Table 4.
Six of the infants in this study had a positive blood culture
result. Two of them had mixed bacteria in their blood cul-
ture. A pathogenic bacterium was detected in blood cul-
tures from 6 of 48 patients, counting for 19.4% (6/31) of
the patients diagnosed with sepsis in this study. Ten
patients had a positive PCR however, one was diagnosed
with asphyxia and not sepsis, therefore 29.0% (9/31) of
patients were diagnosed with sepsis. Correlation between
the results from PCR and blood culture was not obvious.
One patient with a positive blood culture had a negative
PCR result, and another patient had an inconclusive PCR
result. Six patients had a positive PCR in spite of a negative
blood culture. Compared to blood culture the diagnosis
of bacterial sepsis in the newborn by PCR revealed 66.7%
sensitivity, 87.5% specificity, 95.4% positive and 75%
negative predictive value. Altogether, PCR and/or blood
culture detected bacteria in 35.5% (11/31) of the patients
with the diagnosis of sepsis. In our study, compared to the
diagnosis of sepsis, PCR had 29.0% sensitivity, 94.1% spe-
cificity, 90% positive and 44.4% negative predictive val-
ues.
Risk factors, clinical signs and laboratory parameters in S 
(sepsis) versus nS (not sepsis)
Results are presented in Table 1.
Known risk factors [1,19] such as maternal fever with
temp. > 38°C at delivery and ruptured membranes > 12
hours before delivery were not significantly higher in the
group with sepsis. Neither did discolouration of amniotic
fluid, instrumental intervention during birth or Apgar
score of < 7 at 1 min. differ significantly between the two
groups (data not shown in Table 1). Apgar scores < 8 at 5
min and infants with gestational ages < 37 weeks were sig-
nificant higher in the non-septic group. Clinical signs of
sepsis, such as fever in the newborn (defined as rectal
temp. > 38°C), and tachycardia (defined as heart rate >
160 beats per minute), did not correlate significantly with
either of the two groups. Furthermore, respiratory signs
seemed to be particularly unspecific, since tachypnoea
with respiratory rate (RR) > 60/min., abnormal respira-
tory pattern, oxygen saturation (SaO2) < 88% and abnor-
mal thoracic x-ray (data not shown), did not correlate
with either of the two groups. Irritability and feeding dif-
ficulties seemed to be the only clinical signs to be trusted
in our study when diagnosing sepsis in the newborn.
Infants in the not sepsis group presented more often with
base excess < -5 on admittance to the NICU. Patients in
the sepsis group had mean CRP concentrations of 47.0
Table 3: Comparison of broad range 16 S rDNA and conventional Bactec blood culture
Number of patients Broad Range 16 S rDNA PCR
Sepsis Negative Positive
Bactec + 6# 2* 4
Bactec - 25 20 5
Not sepsis
Bactec + 0 0 0
Bactec - 17 16 1
# Culture from one patient grew four organisms (Klebsiella spp, Escherichia coli, a viridans Streptococcus and Staphylococcus aureus), culture from 
another patient grew two organisms (an unnamed viridans Streptococcus and Streptococcus gordomitis). Both had a positive PCR-result and were 
diagnosed with sepsis based on additional clinical and laboratory findings.
* One of these patients had an inconclusive PCR.Page 5 of 8
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to the NICU, and 66.8 (CI 30.1–103.5) mg/L as highest
CRP during treatment. The non-sepsis group had mean
CRP concentrations of 8.5 (CI 6–11) mg/L at admittance
to the NICU, and 9.1 (CI 6.4–11.8) mg/L as highest CRP
during treatment.
Risk factors, clinical signs and laboratory parameters in 
"bacterial proven sepsis" versus "non-proven sepsis"
Results are presented in Table 2.
Maternal fever at delivery was more commonly seen in
infants in whom a pathogenic agent was not detected.
Although instrumental intervention, discolouration of
amniotic fluid and a low Apgar score tended to be over-
represented in infants with non-proven sepsis, no other
risk factors analysed discriminated significantly between
the two groups. Capillary filling time > 3 sec. together
with respiratory rate > 60 breaths per min. were observed
more often in non-proven sepsis, while irritability was
seen more often in infants with proven sepsis, although
none of these findings were significant. No laboratory
parameters analysed differed significantly between the
two groups, but an abnormal platelet level seemed to be
more common in infants with proven sepsis.
Discussion
Comparison of 16S rDNA PCR and blood culture for 
detecting bacteria in newborns with signs of sepsis
In the present study the diagnosis of bacterial sepsis in the
newborn by PCR revealed 66.7% sensitivity, 87.5% specif-
icity, 95.4% positive and 75% negative predictive value.
While neonatal sepsis was diagnosed in 31 out of the 48
patients enrolled in the study, a pathogenic bacterium was
detected in the blood culture of only 19.4% of these
patients. With the molecular method of broad range 16S
rDNA PCR, the detection of bacteria improved to 29.0%.
As the total number of patients was low this difference did
not obtain statistical significance. Based on the criteria
used for the diagnosis of sepsis, these two methods com-
bined had a sensitivity of 35.5%.
Six patients tested positive for broad range bacterial PCR
but had negative blood cultures. Five of these six patients
were diagnosed with sepsis. The blood cultures may have
been negative due to inadequate amount of blood drawn
for optimal detection of bacteria [20-22]. Kellogg et al.
[23-25] found that low-level bacteraemia (<10 cfu/ml) is
far more common (up to 68%) in paediatric patients than
previously believed. They concluded that it is necessary to
collect up to 4.5% of the patient's blood volume (approx-
imately 4 ml/kg) in at least two blood cultures to detect
low concentrations of pathogens in the blood. However,
as neonates are very sensitive to even small losses of
blood, collecting more than 1–2 ml of blood is not an
option for this group of patients. With the chosen PCR
Table 4: Microbiological results of Broad Range 16 S rDNA and conventional Bactec blood culture
Broad Range 16 S rDNA PCR Conventional Bactec blood culture
Positive beta-haemolytical Streptococcus gr B
Positive Negative
Positive beta-haemolytical Streptococcus gr B
Inconclusive Staphylococcus lugduensis





Negative Klebsiella, Escherichia coli, Staphylococcus aureus and viridans streptococcus (Mix)
Positive NegativePage 6 of 8
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ml in triplicate extracts of spiked blood samples, not
allowing detection of low level bacteraemia. In one
patient, blood culture was positive (S.aureus) with a con-
cordant negative PCR result. Another patient had a coagu-
lase-negative Staphylococcus in blood culture but an
inconclusive PCR at both 35 and 40 cycles. Both of these
patients were considered as having proven sepsis and the
result could reflect the presence of a low level of live bac-
teria. Even if improving the detection limit, low level
bacteraemia (<10 cfu/ml) in neonates will be difficult to
identify by any method based on detection of bacterial
DNA or growth. To our knowledge, there are no standard-
ised, clinically evaluated tests available for the detection
of pathogenic nucleic acid in blood samples of neonates.
One available PCR based test for detection of pathogenic
DNA in blood of patients with suspected sepsis is devel-
oped by Roche, the LightCycler SeptiFast system. The test
detects a total of 25 pathogenic bacteria and fungi in
blood samples, is standardised and commercially availa-
ble in Europe. However, it is not evaluated for neonates,
and a volume of blood of 3 ml is required.
Jordan et al [14,26,27] showed a higher level of agreement
between the two methodologies when preincubation was
performed before PCR testing. They used 200–500 microl.
EDTA-fullblood preincubated at 37°C for 5 hours before
PCR-testing, and found 96% sensitivity, 99.4% specificity,
and 88.9% positive and 99.8% negative predictive values
for PCR compared with the culturing of 0.5–1.0 ml full
blood with BACTEC 9240. However, a drawback with this
procedure is that only live bacteria, able to grow in blood
culture bottles will be detected. In our study we omitted
the enrichment step and this might explain the difference
between the two methods compared to what was reported
by Jordan et al [12,23,27]. We can not exclude that the six
positive PCR-results without concordant culture-positive
samples could also result from contamination. However,
since five of these patients ended up with the diagnosis of
sepsis based on clinical judgements and a rise in CRP,
contamination seems less likely.
Risk factors, clinical signs and laboratory parameters
The World Health Organization (WHO) has suggested
simple clinical criteria for the diagnosis of sepsis [28].
These criteria are based on studies in children from Ethio-
pia, The Gambia, Papua New Guinea and The Philippines,
less than 91 days of age, who were examined because of
complaints indicating possible infection. These criteria
can not be easily adapted to developed countries where
infants seek earlier medical attention, while symptoms are
still vague. In our study, irritability in the newborn was
the clinical sign observed most often (p = 0.02) in infants
with the diagnosis of sepsis. The absence of the other clin-
ical criteria suggested by WHO could be explained by the
small number of patients with serious bacterial illness in
our study [29]. Maternal fever during labour (p = 0.02)
was more common in infants with non-proven sepsis,
which may be explained by the fact that mothers with
fever at delivery were more often given prophylactic anti-
biotic therapy. CRP is the most commonly used marker
for identifying neonates with sepsis [2,15]. It has previ-
ously been suggested that serial elevated CRP levels are
more appropriate than a single CRP measurement in diag-
nosing sepsis [3]. Previously, authors have operated with
different cut off points for CRP in the diagnosis of neona-
tal clinical septicemia [2,3]. In this study, we did not oper-
ate with any clear cut off points in CRP before starting
treatment. In view of these statements, it seems quite
unlikely that neonates in this study with serial normal
CRP levels e.g. < 10 mg/L, did have sepsis.
Conclusion
Different medical conditions may mimic signs of sepsis in
newborns, especially stress during birth. In the present
study, irritability, feeding difficulties and a marked rise in
CRP were important in establishing the diagnosis of sepsis
in the newborn. 16S rDNA PCR method used in this study
increased the sensitivity in detecting bacterial DNA in
newborns with signs of sepsis, although not significantly.
PCR has potential as a method for earlier detection of bac-
teria but this technology needs to be further developed
and improved. Blood culture is irreplaceable at present,
since pure isolates are essential for antimicrobial drug sus-
ceptibility testing.
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